BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca

  Cellectis announced it has entered into a Joint Research Collaboration Agreement, an investment agreement relating to an initial equity investment of $80M, and a memorandum of understanding relating to an additional equity investment of $140M, with AstraZeneca.

  November 1, 2023

   · 

  9 min read
• Business

  RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

  RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced the appointment of Tim Van Hauwermeiren to its board of directors.

  November 1, 2023

   · 

  4 min read
• NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support

  NorthX Biologics AB is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV vectors for gene therapy.

  November 1, 2023

   · 

  2 min read